EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification and Drug Screening of Single Cells from Human Tumors on Semiconductor Chip for Cancer Precision Medicine

Wenhao Hui, Ka-Meng Lei, Yingying Liu, Xinru Huang, Yunlong Zhong, Xiaojun Chen, Mingji Wei, Jie Yan, Ren Shen, Pui-In Mak, Rui P Martins, Shuhong Yi und 2 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202503131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Wenhao Hui und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Analog and Mixed-Signal VLSI, Institute of Microelectronics, University of Macau, Taipa, 999078, Macau. Hauptthemen laut MEDLINE: Precision Medicine, Single-Cell Analysis, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Macau Science and Technology Development Fund, University of Macau, Dr. Stanley Ho Medical Development Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug screening of primary tumor cells directly assesses the drug efficacy on specific tumors, promoting personalized cancer treatment. The application of a microfluidic platform has realized drug screening using a limited amount of biopsy samples for cancer precision medicine. However, all the techniques face an inevitable issue of not all the primary tumor cells being cancer cells. Here, a system is introduced that integrates single‐cell identification and drug screening on one semiconductor chip so that both drug efficacy on cancer cells and drug toxicity on noncancerous cells can be obtained simultaneously. An integrated circuit is built on the semiconductor chip for single‐cell electric impedance sensing (IC‐ECIS) of ultra‐weak signals for distinguishing cancer cells from noncancerous cells without affecting cell vitality. Single‐cell identification is validated using breast, lung, and liver cell lines as well as liver cancer specimens from clinical patients. The accuracy on commercial cell lines is ≈80%, and the diagnostic results of tumor tissues are consistent with clinical pathology results. Drug screening is run on the same chip after single cell identification for dual evaluation of drug efficacy and toxicity in both breast cancer models and clinical liver cancer patients. The on‐chip drug screening is confirmed with off‐chip counterpart experiments in breast cell lines. The effectiveness or ineffectiveness of a drug screened on the IC‐ECIS chip demonstrated consistency in the presence or absence of specific mutations in the drug‐related genes determined via exome sequencing of individual liver tumors, validating the method for precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineSingle-Cell AnalysisNeoplasmsAntineoplastic AgentsHumansSemiconductorsCell Line, TumorDrug Screening Assays, AntitumorLab-On-A-Chip Devices

Stichwörter der Autor:innen

cell impedancedrug screeningintegrated circuit (IC)precision medicinesingle cell

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Analog and Mixed-Signal VLSI, Institute of Microelectronics, University of Macau, Taipa, 999078, Macau.
  • Faculty of Science and Technology, University of Macau, Taipa, 999078, Macau.
  • Liver Transplantation Center, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510000, China.
  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510000, China.
  • Lingnan Normal University, Zhanjiang, 524000, China.
  • Electrical and Information Engineering, Jiangsu University, Zhenjiang, 212000, China.

ORCID-Profile: Yanwei Jia

Förderung

  • Macau Science and Technology Development Fund
  • University of Macau
  • Dr. Stanley Ho Medical Development Foundation
  • Jiangsu Provincial Department of Science and Technology
  • Universidade de Macau

Zitieren

APA

Hui, W., Lei, K. M., Liu, Y., Huang, X., Zhong, Y., Chen, X., Wei, M., Yan, J., Shen, R., Mak, P. I., Martins, R. P., Yi, S., Wang, P., & Jia, Y. (2025). Identification and Drug Screening of Single Cells from Human Tumors on Semiconductor Chip for Cancer Precision Medicine. Advanced Science. https://doi.org/10.1002/advs.202503131

Vancouver

Hui W, Lei KM, Liu Y, Huang X, Zhong Y, Chen X, et al. Identification and Drug Screening of Single Cells from Human Tumors on Semiconductor Chip for Cancer Precision Medicine. Advanced Science. 2025. doi:10.1002/advs.202503131

BibTeX
@article{Hui2025,
  author = {Hui, Wenhao and Lei, Ka-Meng and Liu, Yingying and Huang, Xinru and Zhong, Yunlong and Chen, Xiaojun and Wei, Mingji and Yan, Jie and Shen, Ren and Mak, Pui-In and Martins, Rui P and Yi, Shuhong and Wang, Ping and Jia, Yanwei},
  title = {Identification and Drug Screening of Single Cells from Human Tumors on Semiconductor Chip for Cancer Precision Medicine},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202503131}
}
Kostenlos starten →